Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ERAS compared with MAZE: revenue, margins and what each company keeps, and the suppliers and customers both name
ERAS
Erasca, Inc.
Change
Mkt cap
Revenue
Revenue
MAZE
Maze Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ERAS
Erasca, Inc.
vs
MAZE
Maze Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
ERAS
with
MAZE
Uncorrelated: r 0.17 · 424D.
Shared co-movers
1
with ERAS
with MAZE
IDYA
IDEAYA Biosciences, Inc.
r 0.34
r 0.29
ERAS, solid
MAZE, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
ERAS
Erasca, Inc.
Change
14.85
▲
+5.66%
Mkt cap
$4.9B
Revenue
—
MAZE
Maze Therapeutics, Inc.
Change
32.09
▲
+5.65%
Regular session
Nov 3 '26
Mkt cap
$1.8B
Revenue
$20M
Q1 FY26
vs
Compare
Regular session
Nov 3 '26
ERAS
Erasca, Inc.
vs
MAZE
Maze Therapeutics, Inc.
14.85
▲
+5.66%
Price
32.09
▲
+5.65%
$4.9B
Mkt cap
$1.8B
—
Revenue
$20M
Q1 FY26
Change
Change
ERAS
14.85
▲
+5.66%
vs
MAZE
32.09
▲
+5.65%
Regular session
Nov 3 '26